Robert G. Biscontri

Colleen J. Metge1
Irina Vasilyeva1
Murray W. Enns1
1Colleen J. Metge
1Irina Vasilyeva
1Murray W. Enns
Learn More
BACKGROUND Despite concerns over the potential for severe adverse events, antipsychotic medications remain the mainstay of treatment of behaviour disorders and psychosis in elderly patients. Second-generation antipsychotic agents (SGAs; e.g., risperidone, olanzapine, quetiapine) have generally shown a better safety profile compared to the first-generation(More)
  • 1